Sumaham, Glenn R.

HRN: 27-58-95  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
CEFTRIAXONE 1G (VIAL)
08/08/2025
08/14/2025
IV
2 Grams
IV
Cap Mr
Remove - Pending Acceptance
08/08/2025
AZITHROMYCIN 500MG TABLET (TAB)
08/08/2025
08/14/2025
PO
500
OD
Pneumonia
Remove - Pending Acceptance
08/10/2025
FLUCONAZOLE 150MG (CAP)
08/10/2025
08/17/2025
PO
150mg
OD
Esophageal Candidiasis
Remove - Pending Acceptance
08/13/2025
OXACILLIN 500MG (VIAL)
08/13/2025
08/19/2025
IVTT
500 Mg
Q6
Sepsis
Remove - Pending Acceptance
08/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/14/2025
08/21/2025
IV
4.5g
Q8
Pneumoni On An Immunocompromised Host
Remove - Pending Acceptance
08/16/2025
AZITHROMYCIN 500MG TABLET (TAB)
08/16/2025
08/23/2025
PO
2 Tabs
As Maintenance
For MAC Prophylaxis In An Immunocompromised Patient
Remove - Pending Acceptance
08/21/2025
COTRIMOXAZOLE 960MG (TAB)
08/21/2025
08/28/2025
PO
960ng
Q6hr
Sepsis
Checking Initial Appropriateness 
08/23/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/23/2025
08/30/2025
IVTT
4.5
Q8H
Pneumonia In Immunocompromised State
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: